这是一篇来自已证抗体库的有关
人类 SF-1 (SF-1) 的综述，是根据11篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合SF-1 抗体。
SF-1 同义词: AD4BP; ELP; FTZ1; FTZF1; POF7; SF-1; SF1; SPGF8; SRXX4; SRXY3; hSF-1
赛默飞世尔
| 小鼠 单克隆（N1665） | - 免疫组化-石蜡切片; 小鼠; 1:300; 图 1a
| 赛默飞世尔SF-1抗体（Thermo Fisher Scientific, 434200)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:300 (图 1a). elife (2021) ncbi |
| 小鼠 单克隆（N1665） | | 赛默飞世尔SF-1抗体（Thermo Fisher Scientific, 434200)被用于被用于免疫组化在小鼠样本上浓度为1:200 (图 5b). Development (2017) ncbi |
| 小鼠 单克隆（N1665） | | 赛默飞世尔SF-1抗体（Invitrogen, N1665)被用于被用于免疫组化在人类样本上浓度为1:200 (图 2a). J Clin Invest (2017) ncbi |
| 小鼠 单克隆（N1665） | | 赛默飞世尔SF-1抗体（Invitrogen, N1665)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Endocr Pathol (2016) ncbi |
| 小鼠 单克隆（N1665） | | 赛默飞世尔SF-1抗体（Invitrogen, N1665)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6). Endocrinology (2014) ncbi |
| 小鼠 单克隆（N1665） | | 赛默飞世尔SF-1抗体（Invitrogen, 434200)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Eur J Cancer (2013) ncbi |
| 小鼠 单克隆（N1665） | | 赛默飞世尔SF-1抗体（Invitrogen, MAB 434200)被用于被用于免疫组化-石蜡切片在人类样本上 (图 6). Eur J Endocrinol (2012) ncbi |
| 小鼠 单克隆（N1665） | - 免疫组化-冰冻切片; 人类; 1:200; 图 5
| 赛默飞世尔SF-1抗体（Invitrogen, 434200)被用于被用于免疫组化-冰冻切片在人类样本上浓度为1:200 (图 5). FASEB J (2011) ncbi |
艾博抗（上海）贸易有限公司
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司SF-1抗体（Abcam, ab65815)被用于被用于免疫组化在小鼠样本上浓度为1:300 (图 3e). Oncogene (2020) ncbi |
| domestic rabbit 单克隆 | | 艾博抗（上海）贸易有限公司SF-1抗体（Abcam, ab168380)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 3d). J Cell Mol Med (2019) ncbi |
| | | 艾博抗（上海）贸易有限公司SF-1抗体（Abcam, ab115702)被用于被用于免疫印迹在人类样本上. J Biol Chem (2015) ncbi |
Russell J, Lim X, Santambrogio A, Yianni V, Kemkem Y, Wang B,
et al. Pituitary stem cells produce paracrine WNT signals to control the expansion of their descendant progenitor cells. elife. 2021;10:
pubmed 出版商 Borges K, Pignatti E, Leng S, Kariyawasam D, Ruiz Babot G, Ramalho F,
et al. Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice. Oncogene. 2020;39:5282-5291
pubmed 出版商 Huang H, Zou X, Zhong L, Hou Y, Zhou J, Zhang Z,
et al. CRISPR/dCas9-mediated activation of multiple endogenous target genes directly converts human foreskin fibroblasts into Leydig-like cells. J Cell Mol Med. 2019;:
pubmed 出版商 Haston S, Pozzi S, Carreno G, Manshaei S, Panousopoulos L, González Meljem J,
et al. MAPK pathway control of stem cell proliferation and differentiation in the embryonic pituitary provides insights into the pathogenesis of papillary craniopharyngioma. Development. 2017;144:2141-2152
pubmed 出版商 Buonocore F, Kühnen P, Suntharalingham J, Del Valle I, Digweed M, Stachelscheid H,
et al. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest. 2017;127:1700-1713
pubmed 出版商 Manojlović Gacić E, Skender Gazibara M, Popovic V, Soldatovic I, Boricic N, Raičević S,
et al. Oncogene-Induced Senescence in Pituitary Adenomas--an Immunohistochemical Study. Endocr Pathol. 2016;27:1-11
pubmed 出版商 Lee J, Lee Y, Lim J, Byun H, Park I, Kim G,
et al. Mitochondrial Respiratory Dysfunction Induces Claudin-1 Expression via Reactive Oxygen Species-mediated Heat Shock Factor 1 Activation, Leading to Hepatoma Cell Invasiveness. J Biol Chem. 2015;290:21421-31
pubmed 出版商 Lewis S, Hedman C, Ziegler T, Ricke W, Jorgensen J. Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation. Endocrinology. 2014;155:358-69
pubmed 出版商 Kuhn E, Ayhan A, Shih I, Seidman J, Kurman R. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium. Eur J Cancer. 2013;49:3839-49
pubmed 出版商 Straume A, Løvås K, Miletic H, Gravdal K, Lønning P, Knappskog S. Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour. Eur J Endocrinol. 2012;166:941-9
pubmed 出版商 Ferraz de Souza B, Lin L, Shah S, Jina N, Hubank M, Dattani M,
et al. ChIP-on-chip analysis reveals angiopoietin 2 (Ang2, ANGPT2) as a novel target of steroidogenic factor-1 (SF-1, NR5A1) in the human adrenal gland. FASEB J. 2011;25:1166-75
pubmed 出版商
